GENERAL ATLANTIC, L.P.

Position in RVMD — Revolution Medicines, Inc.

CIK 1017645 New York, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$68,832,674

-$155,217,041 QoQ

Shares Held

707,791

-74.8% QoQ

Ownership

0.333%

of shares outstanding

% of Portfolio

3.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GENERAL ATLANTIC, L.P. holds $413,108,297 across 4 Biotechnology names. RVMD ranks #2 (16.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHVS	Pharvaris N.V.	8,031,252	$226,882,869
2	RVMD	Revolution Medicines, Inc. This page	707,791	$68,832,674
3	NRIX	Nurix Therapeutics, Inc.	4,101,865	$63,578,907
4	CNTA	Centessa Pharmaceuticals plc	1,354,830	$53,813,847

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$68,832,674	707,791	-74.8%	Shares	Sole	2026-05-15
2025-12-31	$224,049,715	2,812,928	+13.7%	Shares	Sole	2026-02-17
2025-09-30	$115,555,787	2,474,428	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.